Web Results

New Shingles Vaccine May Have Higher Efficacy in Older Adults

www.medscape.com/viewarticle/868816

Sep 15, 2016 ... A new two-dose herpes zoster vaccine called HZ/su is safe and reduces the risk for shingles and postherpetic neuralgia by nearly 90% in ...

Have Shingles? There's a New Vaccine for That! | American Council ...

acsh.org/news/2016/09/16/have-shingles-theres-new-vaccine-10168

Sep 16, 2016 ... Shingles is most often seen in older people and those whose immune system is compromised for various reasons. The Zostavax vaccine ...

New Shingles Vaccine May Offer Improved Protection - The New ...

well.blogs.nytimes.com/2015/04/29/new-shingles-vaccine-may-offer-improved-protection/

Apr 29, 2015 ... An investigational shingles vaccine may be more effective, particularly in older people.

GSK's candidate shingles vaccine shows high efficacy against ...

www.gsk.com/en-gb/media/press-releases/2016/gsk-s-candidate-shingles-vaccine-shows-high-efficacy-against-shingles-and-its-complications-in-adults-aged-70-years-and-over-in-phase-iii-study-published-in-nejm/

Sep 14, 2016 ... GSK's candidate shingles vaccine shows high efficacy against ... The results were published in the New England Journal of Medicine (NEJM).

New shingles vaccine expected in 2017 won't weaken over time

palmbeachhealthbeat.blog.palmbeachpost.com/2015/07/13/new-shingles-vaccine-expected-in-2017-wont-weaken-over-time/

Jul 13, 2015 ... You've seen the commercials. Man with searing pain, lifts up his shirt to friend or wife to show a shingles outbreak that makes you think he'd be ...

New Shingles Vaccine Proving To Be Effective In Testing: Protection ...

www.techtimes.com/articles/177728/20160915/new-shingles-vaccine-proving-to-be-effective-in-testing-protection-still-provided-after-4-years.htm

Sep 15, 2016 ... GSK's experimental vaccine against shingles, named Shingrix, is proving to be effective in testing. In addition to providing highly effective ...

Glaxo Is Asking the FDA to Approve This New Shingles Drug, Shingrix

fortune.com/2016/10/24/glaxosmithkline-shingrix-fda-approval-files/

Oct 24, 2016 ... Incoming CEO Emma Walmsley needs to refresh its portfolio. GlaxoSmithKline GSK 1.07% has filed its shingles vaccine Shingrix for U.S. ...

New shingles vaccine delivers whopping efficacy | Family Practice ...

www.mdedge.com/familypracticenews/article/101968/infectious-diseases/new-shingles-vaccine-delivers-whopping

Aug 17, 2015 ... The investigational HZ/su vaccine looks like it could be the herpes zoster vaccine of the future for older adults, Dr. Laura P. Hurley said at a ...

New Shingles Vaccine Works Better - NBC News

www.nbcnews.com/health/health-news/new-shingles-vaccine-works-better-n350566

Apr 29, 2015 ... A new vaccine to protect people against shingles seems to work better than the current vaccine, protecting more than 97 percent of people.

GSK's Slaoui sees 'major' vaccine market disruption for Merck as ...

www.fiercepharma.com/sales-and-marketing/gsk-s-slaoui-sees-major-vaccine-market-disruption-for-merck-as-shingles

Jan 13, 2016 ... GlaxoSmithKline expects its shingles candidate, Shingrix, to be a "major ... " Shingrix can be the spearheading vaccine to a new generation of ...

Answer
Find Health Information on Healthline
Find Info About:
Healthline is the leading provider of health information.
More Info

Experimental Shingles Vaccine Looks Effective - WebMD

www.webmd.com

Sep 14, 2016 ... 14, 2016 (HealthDay News) -- An experimental vaccine against shingles may offer lasting protection for most older adults who receive it, a new ...

GSK shingles vaccine remains effective after 4 years: study | Fox News

www.foxnews.com

Sep 15, 2016 ... The latest four-year data on Shingrix, which appears in the New England Journal of ... Shingles vaccine not cost effective before age 60 ...

Glaxo Seeks FDA Approval for Experimental Shingles Vaccine ...

www.bloomberg.com

Oct 24, 2016 ... Glaxo Seeks FDA Approval for Experimental Shingles Vaccine. by ... to results published in the New England Journal of Medicine on Sept. 14.